ArticleFrontiers in veterinary science2025
Microencapsulated medium-chain fatty acids as an antibiotic alternative improve intestinal immunity and microbiota composition in weaned piglets.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimization of Litsea cubeba ethanol extract and its antibacterial mechanism against Staphylococcus aureus.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate effects of microencapsulated medium-chain fatty acids (MCFA) on growth performance, antioxidant capacity, immune response, and gut microbiota in weaned piglets. Materials and methods: A total of 120 weaned piglets (Initial BW 6.38 ± 1.03 kg) were randomly assigned to one of three dietary treatments for a 42-day trial: a corn-soybean meal basal diet (CON), a diet supplemented with 150 mg/kg colistin sulfate (AGP), or a diet supplemented with 0.15% microencapsulated MCFA (MOA), with 5 replicates of 8 piglets per treatment. Results: During the overall period, the MOA group exhibited a higher average daily feed intake than both the CON and AGP groups ( Conclusion: Dietary supplementation with 0.15% microencapsulated MCFA promoted feed intake, optimized intestinal microbiota composition and metabolism, and alleviated intestinal inflammation in weaned piglets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.